Arrowhead (ARWR) announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference therapeutic designed to reduce liver production of ...
From bathrobes to baby gates, several child and baby products are under safety recalls by the U.S. Consumer Product Safety Commission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback